Upgrade to SI Premium - Free Trial

MBCOF (MBCOF)

0.15 -0.01 (6.25%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Marvel Biosciences to Participate and Present at the 2nd Neuroscience Innovation Partnering and Licensing Summit April 23, 2026 7:30 AM - Globe NewsWire Marvel Biosciences Identifies Liquid Formulations for Neurodevelopmental Disorders April 16, 2026 7:00 AM - Globe NewsWire Marvel Biosciences secures funding for autism drug trial from 5 Horizons April 7, 2026 12:26 PM - StreetInsider Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures April 7, 2026 12:26 PM - Globe NewsWire Marvel Biosciences secures funding for autism drug trial April 7, 2026 7:37 AM - StreetInsider Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204 March 30, 2026 7:30 AM - Globe NewsWire Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204 March 25, 2026 7:30 AM - Globe NewsWire Marvel Biosciences receives US patent for autism drug candidate MB-204 March 18, 2026 7:02 AM - StreetInsider Marvel Biosciences Receives Notice of Allowance for US Patent Application Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204 March 18, 2026 7:02 AM - StreetInsider Full Article List